Takeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead Pharmaceutical Technology 14:12
Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments Boston Globe 12:30 Article paywall
Takeda’s Orzeyful approved in US as first-in-class orexin treatment for narcolepsy Type 1 European Pharmaceutical Review 11:59
U.S. FDA Approves Takeda’s Orzeyful™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 Business Wire (Press Release) 23:12 Wed, 05 Aug
STAT Plus: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments STAT 21:46 Wed, 05 Aug
Takeda aims for dengue vaccine inclusion in India's shots program Nikkei Asian Review 02:46 Wed, 05 Aug Article paywall
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track Business Wire (Press Release) 07:37 Thu, 30 Jul
Takeda Sees Qdenga India Launch By Mid-2027, Panacea Closest Competitor Scrip Pharma Intelligence 10:49 Thu, 23 Jul
Takeda’s zasocitinib shows high rates of skin clearance in phase 3 psoriasis studies PMLiVE 13:03 Wed, 22 Jul
India approves its first dengue vaccine, from Japan's Takeda Nikkei Asian Review 15:03 Tue, 21 Jul Article paywall
Japanese drugmaker Takeda’s Qdenga becomes first dengue vaccine approved in India The Straits Times 20:10 Mon, 20 Jul
Novartis and Takeda drugs gain rare blood cancer routine use on NHS Pharmaceutical Technology 14:44 Mon, 20 Jul
Takeda’s Qdenga approved in India, can be given despite pre-exposure to dengue The Hindu Business Line 12:23 Mon, 20 Jul
Takeda gets Dcgi approval for Qdenga, India's first dengue vaccine The Business Standard 09:23 Mon, 20 Jul
Takeda Biopharmaceuticals gets Dcgi nod for dengue vaccine Qdenga The Economic Times 06:59 Mon, 20 Jul
Oral Psoriasis Drug From Takeda Demonstrates Strong Skin Clearance in Trials Benzinga 18:12 Fri, 17 Jul Article paywall
Takeda unveils secondary endpoint data from Phase III PsO pill trials Clinical Trials Arena 11:22 Fri, 17 Jul
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies Business Wire (Press Release) 23:07 Thu, 16 Jul
Inside Takeda’s transformation: The pipeline strategy behind its next growth chapter Labiotech 14:07 Tue, 14 Jul
Takeda's mezagitamab adds quality-of-life gains to Itp responses BioWorld 20:27 Mon, 13 Jul Article paywall
Takeda and Indonesia partner on plasma-derived therapies Pharmaceutical Business Review 10:47 Mon, 13 Jul
Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products Business Wire (Press Release) 00:04 Mon, 13 Jul
Takeda Pharmaceutical (TSE:4502) Taps Pharma.AI For Drug Discovery, Is The Stock Still Cheap? Simply Wall St 18:03 Fri, 10 Jul
Insilico Medicine Announces Collaboration With Takeda To Advance Strategic AI Drug Discovery Drugs Discovery Online 08:11 Thu, 09 Jul